Members of the BioVentures team attended the BIO International Convention, held June 22–25 in San Diego, California, joining more than 20,000 biotechnology professionals from around the world.
Develop commercialization skills through BioVentures’ year-long CADET program. Applications close Aug. 7.
BioVentures has released a new podcast episode featuring Dr. Marie Burdine, a member of the most recent AR Health Ventures Accelerator cohort. In the episode, she discusses her team’s research on a drug designed to reduce delayed graft function (DGF), a complication that can occur following kidney transplantation. DGF affects approximately 30% of kidney transplant recipients and is often associated with damage to donor kidneys during transport. Dr. Burdine’s team is evaluating whether adding the drug to organ preservation solutions can reduce injury and improve recovery after transplantation using a preclinical pig transplant model. According to the discussion, early findings indicate faster recovery of kidney function and reduced tissue injury. The research aims to improve transplant outcomes and increase the number of donor organs suitable for transplantation.
Newly issued patent enables patient-specific coronary CTA imaging by predicting cardiac motion to improve image quality and accuracy.
UA Little Rock will host Pitches & Demos for the AI Hackathon & HealthTech Startup Week on Friday, June 12, from 2:00 to 5:00 p.m. at the Engineering & Information Technology Auditorium.
Dr. Anthony Gunderman discussed how engineering and robotics can help address clinical needs during a recent UAMS Research & Innovation seminar.
Join BioVentures Innovation Day 2026 to connect, explore healthcare innovation, and turn discoveries into real-world impact at UAMS.
BioVentures celebrated CADET’s inaugural cohort with final pitches, awards, and hands-on training in biomedical entrepreneurship and commercialization.
The UAMS team, connected to the Medical Innovation and Entrepreneurship Honors Track (MIEHT), earned both the Biodesign Competition award and the People’s Choice Award for ARGUS, a project designed to better protect physicians during image-guided procedures.
In this episode of the BioVentures Podcast, we sit down with Dr. Kevin W. Sexton (surgeon, scientist, and former BioVentures president) to explore his journey from clinical practice to successful health tech innovation. Dr. Sexton shares how early exposure to entrepreneurship and key mentorship moments led him to develop predictive healthcare software later acquired by a Fortune 500 company and reflects on the lessons learned from both successes and failures along the way. Our conversation dives into the realities of innovation in healthcare, from navigating complex adoption barriers and aligning stakeholders, to choosing between software and medical device solutions. Dr. Sexton emphasizes the importance of focusing on real problems, understanding customer needs, and creating true value in the market. He also discusses emerging trends in digital health, including the growing role of AI, faster development cycles, and the evolving landscape of software as a medical device. Whether you’re a researcher, clinician, or aspiring entrepreneur, this episode offers practical insights on commercialization, startup strategy, and how innovation can become a meaningful part of an academic career.
